
    
      To observe the effects of oxytocin on individuals with autism spectrum disorder according to
      gender, in facial recognition and eye tracking tests. The investigators will apply the nepsy
      and eye tracking tests before and 45 minutes after the puff with oxytocin or placebo at the
      dose of 0.4 IU / kg / dose maximum of 24 IU. The next week the volunteer will return and will
      do the same procedure because whoever took the placebo would take oxytocin and vice versa. Is
      a randomized, double-blind, placebo-controlled clinical trial.
    
  